Zobrazeno 1 - 1
of 1
pro vyhledávání: '"brentuximab, Hodgkin's lymphoma"'
Autor:
Vincenzo Pavone, Corrado Schiavotto, Elena Cavalieri, Michele Spina, Gian Matteo Rigolin, Stefano Molica, Antonello Pinto, Anna Marina Liberati, Stefano Volpetti, Luigi Rigacci, Giuseppe Gritti, Monica Tani, Patrizio Mazza, Paolo Corradini, Alessandra Romano, Pellegrino Musto, Maurizio Bonfichi, Stefan Hohaus, Chiara Rusconi, Guido Gini, Patrizia Tosi, Pier Luigi Zinzani, Lisa Argnani, Alessandro Broccoli, Angelo Michele Carella, Fioravante Ronconi, Donato Mannina, Filippo Gherlinzoni, Alessandro Pulsoni, Daniele Vallisa, Amalia De Renzo, Michele Merli, Andrea Visentin, Barbara Botto, Maria Goldaniga, Anna Vanazzi, Caterina Patti, Armando Santoro, Francesco Gaudio, Angelo Fama
Publikováno v:
Blood. 128:4161-4161
From November 2012 to July 2014, brentuximab vedotin (BV) was available in Italy for patients with relapsed Hodgkin's lymphoma (HL) outside a clinical trial context based on a local disposition of the Italian Drug Agency (AIFA) issued according to a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf81ed8f288244dcfaf096903486fe41
https://doi.org/10.1182/blood.v128.22.4161.4161
https://doi.org/10.1182/blood.v128.22.4161.4161
